Recently, studies from two independent groups of researchers suggested that rare variants in the TREM2 (triggering receptor expressed on myeloid cells 2) gene are associated with an increased risk of late-onset AD[124,125]. The gene discussed is TREM2; the disease is Alzheimer disease.